Radiation therapy for BCG-resistant bladder CIS
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests radiotherapy (high-energy X-rays) for a specific type of early-stage bladder cancer (CIS) that hasn't gone away after BCG treatment. It's for people who can't or choose not to have bladder removal surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of bladder cancer called carcinoma in situ (CIS) that is high-risk and did not respond to BCG therapy.
- Your cancer should not have spread into the bladder muscle or to other organs.
- You must be 18 years or older and in reasonably good health (able to do daily activities).
- You should be willing to use effective birth control during and for 4 weeks after treatment.
- You must not have had radiation to the pelvis in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether radiation therapy can help people with early-stage bladder cancer that has a high risk of coming back. It may be an option for those who have not tried BCG treatment.
This trial studies whether bicalutamide can improve outcomes for people with non-muscle-invasive bladder cancer who are starting BCG through the bladder. It may help prevent cancer from coming back or progressing after BCG.
This Phase 2 trial tests TARA-002 given directly into the bladder to treat high-grade non–muscle-invasive bladder cancer with active disease. It may help patients who have not previously responded to, or have not received, BCG treatment in the recent past.
This trial tests whether radiation therapy (high-energy beams to kill cancer cells) can be a good treatment for bladder cancer that hasn't gone away after BCG therapy, offering an alternative to surgery to remove the bladder. It aims to see if this approach can control the cancer while possibly preserving your bladder.
This trial compares two standard treatments for a type of early-stage bladder cancer that has a high chance of coming back. It tests whether radiation therapy combined with a drug that makes cancer cells more sensitive to radiation works as well as or better than BCG, which is a special treatment put directly into the bladder.
This trial tests a new type of radiation therapy that adjusts to your body's changes during treatment. It aims to reduce side effects and improve accuracy for people with bladder cancer.
Hear when a new Non Muscle Invasive Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.